Moderna, Inc. (0QF.F)
EUR 37.5
(-3.85%)
EUR 37.5
(-3.85%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -12.34 USD | -158.04% |
| 2022 | 21.26 USD | -29.86% |
| 2021 | 30.31 USD | 1646.43% |
| 2020 | -1.96 USD | -26.45% |
| 2019 | -1.55 USD | -32.48% |
| 2018 | -1.17 USD | -72.06% |
| 2017 | -0.68 USD | -17.24% |
| 2016 | -0.58 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -3.08 USD | -640.35% |
| 2024 Q2 | -3.33 USD | -8.12% |
| 2023 Q4 | 0.57 USD | 105.98% |
| 2023 FY | - USD | -158.04% |
| 2023 Q1 | 0.20 USD | -94.75% |
| 2023 Q2 | -3.62 USD | -1910.0% |
| 2023 Q3 | -9.53 USD | -163.26% |
| 2022 Q3 | 2.53 USD | -51.72% |
| 2022 FY | - USD | -29.86% |
| 2022 Q2 | 5.24 USD | -38.93% |
| 2022 Q1 | 8.58 USD | -28.68% |
| 2022 Q4 | 3.81 USD | 50.59% |
| 2021 FY | - USD | 1646.43% |
| 2021 Q3 | 8.27 USD | 19.34% |
| 2021 Q1 | 3.05 USD | 542.03% |
| 2021 Q2 | 6.93 USD | 127.21% |
| 2021 Q4 | 12.03 USD | 45.47% |
| 2020 FY | - USD | -26.45% |
| 2020 Q4 | -0.69 USD | -16.95% |
| 2020 Q3 | -0.59 USD | -90.32% |
| 2020 Q2 | -0.31 USD | 11.43% |
| 2020 Q1 | -0.35 USD | 5.41% |
| 2019 FY | - USD | -32.48% |
| 2019 Q1 | -0.40 USD | 6.98% |
| 2019 Q2 | -0.41 USD | -2.5% |
| 2019 Q3 | -0.37 USD | 9.76% |
| 2019 Q4 | -0.37 USD | 0.0% |
| 2018 Q3 | -0.25 USD | -8.7% |
| 2018 Q4 | -0.43 USD | -72.0% |
| 2018 FY | - USD | -72.06% |
| 2018 Q1 | -0.18 USD | -38.46% |
| 2018 Q2 | -0.23 USD | -27.78% |
| 2017 Q4 | -0.13 USD | 0.0% |
| 2017 FY | - USD | -17.24% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 418.863% |
| CureVac N.V. | -1.18 EUR | -945.763% |
| Biotest Aktiengesellschaft | 3.21 EUR | 484.424% |
| Biotest Aktiengesellschaft | 3.21 EUR | 484.424% |
| BRAIN Biotech AG | -0.38 EUR | -3147.368% |
| Formycon AG | 4.76 EUR | 359.244% |
| Heidelberg Pharma AG | -0.44 EUR | -2704.545% |
| Medigene AG | -0.66 EUR | -1769.697% |